Vadimezan
Chemical compound / From Wikipedia, the free encyclopedia
Vadimezan (also known as or ASA404[1] and dimethylxanthone acetic acid or DMXAA) is a tumor-vascular disrupting agent (tumor-VDA) that attacks the blood supply of a cancerous tumor to cause tumor regression.[2]
Quick Facts Clinical data, Other names ...
Clinical data | |
---|---|
Other names | ASA404, DMXAA |
ATC code |
|
Identifiers | |
| |
CAS Number | |
ChemSpider |
|
UNII | |
ChEBI | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.107.097 |
Chemical and physical data | |
Formula | C17H14O4 |
Molar mass | 282.295 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Close